1 CORPORATE GOVERNANCE STATEMENT YEAR ENDING 30 JUNE 2026 Clarity Pharmaceuticals Ltd ACN 143 005 341 (the Company) is committed to continuously improving and achieving high standards of corporate governance. The established governance framework and practices are designed on the basis that good...